Thomas Huling has many years of experience in the finance industry. He is the founder and director and/or Managing Member of many companies, including Global MedInvent, LLC.
Global MedInvent was established in January 2014. The company is a United States based medical technology company established to control operations and strategic business target executions. “We have three core opportunities,” Thomas Huling says, “all focused on accelerating innovations, which provide more options and better results for people in their quest for a healthy life.”
The team at Global MedInvent LLC consists of highly qualified management personnel, strategic partners, and clinicians and researchers. Thomas Huling says they are positioned to either bring the company’s medical technologies to market, or to build on their current successes.
Thomas Huling says Global MedInvent LLC is geared specifically to breakthrough medical inventions and the pharmaceutical industry. He says the company has access to patented micro-invasive diagnostic, devices, and drug delivery technologies that target lung cancer and pulmonary/vascular diseases. These innovative technologies allow access to previously unreachable vessels and passageways. The technology features the world’s smallest surgical camera, and allows the removal of tumors and other obstructions, which paves the way for the localized delivery of drugs.
Global MedInvent LLC also has access to molecule research that targets the delivery of treatments for diabetic retinal disorders, macular degeneration, retinal vascular disease, and genetic retinal disorders.
Thomas Huling says that the company has access to FDA-approved equipment and software that targets the increase in ease and efficiency in retinal pathology detection. He says there have been multiple field trials conducted around the world.